By Counterforce Health Team in Mepsevii (vestronidase alfa-vjbk) —

How to Get Mepsevii (Vestronidase Alfa-vjbk) Covered by Aetna CVS Health in Virginia: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Mepsevii Covered by Aetna CVS Health in Virginia

Mepsevii (vestronidase alfa-vjbk) requires prior authorization from Aetna CVS Health under Clinical Policy Bulletin 0442. Key requirements: confirmed MPS VII diagnosis via enzyme assay or genetic testing, prescription by a metabolic specialist, and elevated urinary glycosaminoglycans ≥2x normal levels. First step: Contact your metabolic specialist today to initiate the Aetna Mepsevii precertification form. If denied, Virginia offers external review through the State Corporation Commission Bureau of Insurance within 120 days.

Table of Contents

Before You Start: Coverage Verification

Confirm Your Plan Type

Verify your Aetna plan covers specialty medications through CVS Caremark or CVS Specialty. Most Aetna commercial plans in Virginia route specialty drugs through CVS, but confirm by:

  • Checking your insurance card for "CVS Caremark" or "CVS Specialty"
  • Calling member services at the number on your card
  • Logging into your Aetna member portal

Formulary Status

Mepsevii appears on Aetna's 2025 Precertification List requiring prior authorization. There are no alternative ERTs for MPS VII, which strengthens your case for approval.

Note: Mepsevii has no step therapy requirements since it's the only FDA-approved enzyme replacement therapy for mucopolysaccharidosis VII.

What You Need to Gather

Essential Documentation

Document Type Specific Requirements Where to Get It
Diagnosis Confirmation Enzyme assay showing β-glucuronidase deficiency OR genetic testing confirming GUSB mutations Metabolic specialist lab results
Clinical Evidence Urinary glycosaminoglycans (uGAG) ≥2x age-normal levels Recent lab work (within 30 days)
ICD-10 Code E76.29 (Other mucopolysaccharidoses) Medical records
Prescriber Credentials Metabolic disease specialist documentation Specialist office
Dosing Calculations Weight-based dosing (4 mg/kg IV every 2 weeks) Clinical notes

Supporting Documents

  • Recent clinic notes documenting MPS VII symptoms
  • Prior therapy attempts and outcomes (if any)
  • Imaging studies showing skeletal involvement
  • Cardiac and pulmonary function assessments

Step-by-Step Prior Authorization Process

Step 1: Specialist Consultation

Your metabolic disease specialist must initiate the process. They'll need to:

  • Confirm MPS VII diagnosis through appropriate testing
  • Document clinical necessity in recent notes
  • Calculate appropriate weight-based dosing

Step 2: Complete the PA Form

Use the Aetna Mepsevii Precertification Form, which includes:

  • Patient demographics and insurance information
  • Clinical details including adverse events history
  • Response to therapy documentation (for continuation requests)
  • Required prescriber signature

Step 3: Medical Necessity Letter

Your specialist should include a comprehensive letter addressing:

  • Diagnosis: Confirmed MPS VII with supporting lab results
  • Clinical rationale: Why Mepsevii is medically necessary
  • No alternatives: Reference that no other ERTs exist for MPS VII
  • Policy alignment: Cite Aetna Clinical Policy Bulletin 0442
  • Monitoring plan: How treatment response will be assessed

Step 4: Submit the Request

Standard submission:

  • Fax to Aetna Precertification: 1-866-752-7021
  • Online via provider portal
  • Allow 5-7 business days for standard review

Expedited submission (if urgent):

  • Include documentation of medical urgency
  • Request 72-hour expedited review
  • Call 1-888-267-2637 for urgent authorizations

Step 5: Coordinate with CVS Specialty

Once approved, your prescription routes to CVS Specialty for fulfillment and infusion coordination (typically 3-5 business days for delivery).

Timeline Expectations

Review Type Timeframe Requirements
Standard PA 5-7 business days Complete documentation
Expedited PA 72 hours Medical urgency documentation
Internal Appeal 30-60 days Filed within 180 days of denial
External Review 45 days standard, 72 hours expedited Filed within 120 days via Virginia BOI

If You Need More Information

Aetna may request additional clinical information such as:

  • More recent lab results
  • Detailed symptom progression notes
  • Imaging studies showing disease progression
  • Confirmation of specialist credentials

Response tip: Provide requested information promptly to avoid delays. Your specialist can submit additional documentation via the same channels used for the initial request.

If Your Request Is Denied

Common Denial Reasons and Solutions

Denial Reason How to Address
Insufficient diagnosis documentation Submit enzyme assay and genetic testing results
Non-specialist prescriber Transfer prescription to metabolic disease specialist
Missing clinical evidence Provide uGAG results and symptom documentation
Experimental/investigational Reference FDA approval and lack of alternatives

Internal Appeals Process

Level 1 Appeal (within 180 days of denial):

  • File via Aetna provider portal or member portal
  • Include denial letter and additional clinical evidence
  • Request peer-to-peer review with medical director
  • Timeline: 30 days for pre-service, 60 days for post-service claims

Level 2 Appeal (within 60 days of Level 1 denial):

  • Reviewed by different medical director
  • Include any new clinical evidence or guideline updates
  • Same timeline as Level 1
From our advocates: We've seen success when specialists emphasize that Mepsevii is the only FDA-approved treatment for MPS VII, making step therapy or alternative trial requirements inappropriate. Including recent clinical guidelines and FDA labeling information strengthens the appeal significantly.

Peer-to-Peer Review

Call 1-888-267-2637 to request a clinical discussion between your specialist and Aetna's medical director. This often resolves denials faster than written appeals alone.

Virginia External Review Process

If internal appeals are exhausted, Virginia offers independent external review through the State Corporation Commission Bureau of Insurance.

Key Requirements

  • File within 120 days of final internal denial
  • Use Form 216-A (External Review Request)
  • Denial must be based on medical necessity, experimental treatment, or similar clinical judgment

Filing Process

Contact Information:

  • Mail: State Corporation Commission Bureau of Insurance, P.O. Box 1157, Richmond, VA 23218
  • Phone: 1-877-310-6560
  • Fax: (804) 371-9915
  • Email: [email protected]

Timeline

  • Standard review: 45 days maximum
  • Expedited review: 72 hours (when delay could jeopardize health)
  • Decision: Binding on both you and Aetna

The Bureau randomly assigns your case to an Independent Review Organization (IRO) with relevant medical expertise. You have 5 business days after case acceptance to submit additional documentation.

For expert guidance navigating Virginia's external review process, Counterforce Health helps patients and clinicians turn insurance denials into targeted, evidence-backed appeals by analyzing denial letters and crafting point-by-point rebuttals aligned with payer policies.

Renewal and Reauthorization

Mepsevii requires reauthorization every 6-12 months. For successful renewal:

Required Evidence

  • Clinical response documentation (improvement, stabilization, or slowed progression)
  • Updated uGAG levels
  • Specialist notes confirming ongoing medical necessity
  • Adverse event monitoring results

Timing

Submit renewal requests 30-45 days before current authorization expires to avoid treatment interruptions.

FAQ

Q: How long does Aetna CVS Health prior authorization take in Virginia? A: Standard requests take 5-7 business days. Expedited reviews (with medical urgency documentation) are completed within 72 hours.

Q: What if Mepsevii is non-formulary on my plan? A: Request a formulary exception citing that no alternative ERTs exist for MPS VII. Include clinical documentation supporting medical necessity.

Q: Can I request an expedited appeal in Virginia? A: Yes, if your treating physician certifies that delay would seriously jeopardize your health. Virginia processes expedited external reviews within 72 hours.

Q: Does step therapy apply to Mepsevii? A: No, Aetna doesn't require step therapy for Mepsevii since it's the only FDA-approved ERT for MPS VII.

Q: What happens if I miss the 120-day external review deadline in Virginia? A: Contact the Bureau of Insurance at 1-877-310-6560. They may consider exceptional circumstances, but filing within the deadline is critical.

Q: Who can help me with the appeals process in Virginia? A: The Virginia State Corporation Commission Bureau of Insurance provides free guidance. Counterforce Health also specializes in turning insurance denials into successful appeals with evidence-backed strategies.

Quick Reference Checklist

Before Starting:

  • Confirm Aetna CVS Health specialty coverage
  • Verify metabolic specialist is in-network
  • Gather insurance card and policy information

Documentation Needed:

  • MPS VII diagnosis confirmation (enzyme assay or genetic testing)
  • uGAG levels ≥2x normal
  • Specialist prescription and clinical notes
  • ICD-10 code E76.29 documentation
  • Weight-based dosing calculations

Submission Process:

If Denied:

  • File Level 1 appeal within 180 days
  • Request peer-to-peer review (1-888-267-2637)
  • If still denied, file Virginia external review within 120 days
  • Contact Bureau of Insurance: 1-877-310-6560

Sources & Further Reading

Disclaimer: This guide provides general information about insurance coverage processes and should not be considered medical advice. Coverage decisions depend on individual circumstances, plan details, and clinical factors. Always consult with your healthcare provider and insurance plan for specific guidance. For personalized assistance with appeals, contact the Virginia State Corporation Commission Bureau of Insurance at 1-877-310-6560.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.